These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 31190787

  • 1. Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.
    Celli BR, Navaie M, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP.
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1019-1031. PubMed ID: 31190787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
    Keshishian A, Xie L, Dembek C, Yuce H.
    Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
    Bollu V, Ernst FR, Karafilidis J, Rajagopalan K, Robinson SB, Braman SS.
    Int J Chron Obstruct Pulmon Dis; 2013 Nov; 8():631-9. PubMed ID: 24353413
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β2-agonists.
    Chen YJ, Makin C, Bollu VK, Navaie M, Celli BR.
    J Med Econ; 2016 Nov; 19(1):11-20. PubMed ID: 26357881
    [Abstract] [Full Text] [Related]

  • 8. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J, Dik N, Bugden S.
    Int J Chron Obstruct Pulmon Dis; 2016 Nov; 11():3101-3108. PubMed ID: 27994449
    [Abstract] [Full Text] [Related]

  • 9. Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.
    Navaie M, Celli BR, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP.
    Chronic Obstr Pulm Dis; 2019 Oct 23; 6(4):297-307. PubMed ID: 31483988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners.
    Meeraus W, Wood R, Jakubanis R, Holbrook T, Bizouard G, Despres J, Silva CCD, Nachbaur G, Landis SH, Punekar Y, Aguilaniu B, Ismaila AS.
    Int J Chron Obstruct Pulmon Dis; 2019 Oct 23; 14():51-63. PubMed ID: 30587961
    [Abstract] [Full Text] [Related]

  • 15. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct 23; 9():889-904. PubMed ID: 25210450
    [Abstract] [Full Text] [Related]

  • 16. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 23; 11():2851-2858. PubMed ID: 27920512
    [Abstract] [Full Text] [Related]

  • 17. Initiation of Triple Therapy with Multiple Inhalers in Chronic Obstructive Pulmonary Disease: An Analysis of Treatment Patterns from a U.S. Retrospective Database Study.
    Lane DC, Stemkowski S, Stanford RH, Tao Z.
    J Manag Care Spec Pharm; 2018 Nov 23; 24(11):1165-1172. PubMed ID: 30362922
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.
    Bishwakarma R, Zhang W, Kuo YF, Sharma G.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov 23; 12():477-486. PubMed ID: 28203071
    [Abstract] [Full Text] [Related]

  • 20. Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.
    Baker CL, Zou KH, Su J.
    Int J Chron Obstruct Pulmon Dis; 2014 Nov 23; 9():431-9. PubMed ID: 24833898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.